Jennifer Fine

Jennifer Fine has an extensive background in health economics and outcomes research, with experience at top pharmaceutical companies such as Abivax, Protagonist Therapeutics, Bristol Myers Squibb, Roche, and Genentech. With a Doctorate of Science from Harvard T.H. Chan School of Public Health, as well as a Master of Science and Bachelor of Science in Public Health, Jennifer has a strong educational foundation to support their roles as Senior Vice President Evidence Generation and HEOR, Vice President Evidence and Value, Executive Director HEOR and RWE Cardiovascular, and Senior Director Strategic Innovation, among others.